Axonics Inc (AXNX)
67.43
+0.03
(+0.04%)
USD |
NASDAQ |
May 10, 16:00
67.07
-0.36
(-0.53%)
After-Hours: 20:00
Axonics Enterprise Value: 3.107B for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 3.107B |
| May 09, 2024 | 3.106B |
| May 08, 2024 | 3.102B |
| May 07, 2024 | 3.105B |
| May 06, 2024 | 3.116B |
| May 03, 2024 | 3.100B |
| May 02, 2024 | 3.091B |
| May 01, 2024 | 3.079B |
| April 30, 2024 | 3.063B |
| April 29, 2024 | 3.082B |
| April 26, 2024 | 3.070B |
| April 25, 2024 | 3.062B |
| April 24, 2024 | 3.067B |
| April 23, 2024 | 3.058B |
| April 22, 2024 | 3.077B |
| April 19, 2024 | 3.083B |
| April 18, 2024 | 3.088B |
| April 17, 2024 | 3.096B |
| April 16, 2024 | 3.103B |
| April 15, 2024 | 3.102B |
| April 12, 2024 | 3.116B |
| April 11, 2024 | 3.122B |
| April 10, 2024 | 3.121B |
| April 09, 2024 | 3.124B |
| April 08, 2024 | 3.122B |
| Date | Value |
|---|---|
| April 05, 2024 | 3.129B |
| April 04, 2024 | 3.123B |
| April 03, 2024 | 3.221B |
| April 02, 2024 | 3.183B |
| April 01, 2024 | 3.198B |
| March 31, 2024 | 3.186B |
| March 28, 2024 | 3.173B |
| March 27, 2024 | 3.169B |
| March 26, 2024 | 3.172B |
| March 25, 2024 | 3.161B |
| March 22, 2024 | 3.137B |
| March 21, 2024 | 3.137B |
| March 20, 2024 | 3.162B |
| March 19, 2024 | 3.159B |
| March 18, 2024 | 3.136B |
| March 15, 2024 | 3.114B |
| March 14, 2024 | 3.116B |
| March 13, 2024 | 3.115B |
| March 12, 2024 | 3.105B |
| March 11, 2024 | 3.098B |
| March 08, 2024 | 3.104B |
| March 07, 2024 | 3.095B |
| March 06, 2024 | 3.100B |
| March 05, 2024 | 3.092B |
| March 04, 2024 | 3.102B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
400.43M
Minimum
Mar 18 2020
3.624B
Maximum
Sep 12 2022
2.106B
Average
2.341B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 116.87B |
| Cutera Inc | 318.50M |
| Stereotaxis Inc | 164.80M |
| Electromed Inc | 137.25M |
| Myomo Inc | 101.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.11M |
| Revenue (Quarterly) | 91.41M |
| Total Expenses (Quarterly) | 106.76M |
| EPS Diluted (Quarterly) | -0.38 |
| Gross Profit Margin (Quarterly) | 75.76% |
| Profit Margin (Quarterly) | -20.91% |
| Earnings Yield | -0.47% |
| Normalized Earnings Yield | 0.1416 |